Skip to main content

Table 5 Follow up with VPSV and VPSWOV patients when they returned to hospital 1 month after the operation

From: Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

  

VPSV (n = 13)

VPSWOV (n = 9)

P 1

P 2

P

symptoms improved

headache

12/13(92.3%)

8/9(88.9%)

0.001

<0.001

>0.999

Visual

5/7(71.4%)

5/6(83.3%)

0.374

0.05

>0.999

Auditory

1/2(50%)

2/3(66.7%)

0.371

>0.999

>0.999

 

Mental change

4/5(80%)

1/2(50%)

0.615

0.364

0.333

CSF

CSF pressure (mmH2O) median (range)

158(65–280)

125(50–180)

<0.001

<0.001

0.509

 

WBC count (×106/l) median(range)

14.5(8–46)

21(2–86)

0.014

0.185

0.488

 

Protein, g/L median (range)

0.95(0.15–3.86)

1.31(0.18–2.16)

0.236

0.096

0.692

 

Glucose(mmol/l) median (range)

2.25(1.24–2.89)

2.42(1.27–4.17)

0.384

0.593

0.644

 

Chloride(mmol/l) median (range)

124(114–131)

124(112–130)

0.104

0.264

0.742

 

India ink Cryptococcus count

0(0–266)

0(0–5)

0.004

<0.001

0.377

  1. P1 pre-operation versus returned to hospital after 1 month in the VPSV group
  2. P2 pre-operation versus returned to hospital after 1 month in the VPSWOV group
  3. P VPSV versus VPSWOV when patients returned to hospital 1 month after the operation